Clinical Trials
54
Active:0
Completed:42
Trial Phases
5 Phases
Phase 1:13
Phase 2:1
Phase 3:22
+2 more phases
Drug Approvals
31
FDA:30
NMPA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (48 trials with phase data)• Click on a phase to view related trials
Phase 3
22 (45.8%)Phase 1
13 (27.1%)Not Applicable
8 (16.7%)Phase 4
2 (4.2%)phase_1_2
1 (2.1%)Phase 2
1 (2.1%)phase_2_3
1 (2.1%)No trials found
News
Cadila Pharmaceuticals Launches Biscado (Bisoprolol) to Address India's Cardiovascular Disease Burden
Cadila Pharmaceuticals has launched Biscado (Bisoprolol), a highly cardioselective beta-1 adrenergic blocker, marking its entry into the beta-blocker therapy segment for cardiovascular disease management.